Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'VASSAL G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 47 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dalle, JH; Auvrignon, A; Vassal, G; Leverger, G; Kalifa, C
      Interaction between methotrexate and ciprofloxacin: report of two cases ofsevere intoxication

      ARCHIVES DE PEDIATRIE
    2. Vassal, G; Tranchand, B; Valteau-Couanet, D; Mahe, C; Couanet, D; Schoeppfer, C; Grill, J; Kalifa, C; Hill, C; Ardiet, C; Hartmann, O
      Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma

      BONE MARROW TRANSPLANTATION
    3. Baudin, E; Pellegriti, G; Bonnay, M; Penfornis, A; Laplanche, A; Vassal, G; Schlumberger, M
      Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p ' DDD)levels on the treatment of patients with adrenocortical carcinoma

      CANCER
    4. Doz, F; Gentet, JC; Pein, F; Frappaz, D; Chastagner, P; Moretti, S; Vassal, G; Arditti, J; Van Tellingen, O; Illiadis, A; Catalin, J
      Phase I trial and pharmacological study of a 3-hour paclitaxel infusion inchildren with refractory solid tumours: a SFOP study

      BRITISH JOURNAL OF CANCER
    5. Chastagner, P; Merlin, JL; Marchal, C; Hoffstetter, S; Barberi-Heyob, M; Vassal, G; Duprez, A
      In vivo potentiation of radiation response by topotecan in human rhabdomyosarcoma xenografted into nude mice

      CLINICAL CANCER RESEARCH
    6. Santos, A; Zanetta, S; Cresteil, T; Deroussent, A; Pein, F; Raymond, E; Vernillet, L; Risse, ML; Boige, V; Gouyette, A; Vassal, G
      Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans

      CLINICAL CANCER RESEARCH
    7. Oberlin, O; Brugieres, L; Patte, C; Kalifa, C; Vassal, G; Valteau-Couanet, D; Hartmann, O
      Recent progress in pediatric oncology.

      ARCHIVES DE PEDIATRIE
    8. Valteau-Couanet, D; Benhamou, E; Vassal, G; Stambouli, F; Lapierre, V; Couanet, D; Lumbroso, J; Hartmann, O
      Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma

      BONE MARROW TRANSPLANTATION
    9. Griscelli, F; Li, H; Cheong, C; Opolon, P; Bennaceur-Griscelli, A; Vassal, G; Soria, J; Soria, C; Lu, H; Perricaudet, M; Yeh, P
      Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    10. Logie, A; Boudou, P; Boccon-Gibod, L; Baudin, E; Vassal, G; Schlumberger, M; Le Bouc, Y; Gicquel, C
      Establishment and characterization of a human adrenocortical carcinoma xenograft model

      ENDOCRINOLOGY
    11. Badie, C; Bourhis, J; Sobczak-Thepot, J; Haddada, H; Chiron, M; Janicot, M; Janot, F; Tursz, T; Vassal, G
      p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line

      BRITISH JOURNAL OF CANCER
    12. Vassal, G; Pinkerton, CR
      Experimental therapeutics and new agents for neuroblastoma

      NEUROBLASTOMA
    13. Le Cesne, A; Vassal, G; Farace, F; Spielmann, M; Le Chevalier, T; Angevin, E; Valteau-Couanet, D; Fizazi, K; Cojean, I; Llombard, A; Tursz, T; Escudier, B
      Combination interleukin-2 and doxorubicin in advanced adult solid tumors: Circumvention of doxorubicin resistance in soft-tissue sarcoma?

      JOURNAL OF IMMUNOTHERAPY
    14. Hartmann, O; Valteau-Couanet, D; Vassal, G; Lapierre, V; Brugieres, L; Delgado, R; Couanet, D; Lumbroso, J; Benhamou, E
      Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution

      BONE MARROW TRANSPLANTATION
    15. Lescop, S; Lellouch-Tubiana, A; Vassal, G; Besnard-Guerin, C
      Molecular genetic studies of chromosome 11 and chromosome 22q DNA sequences in pediatric medulloblastomas

      JOURNAL OF NEURO-ONCOLOGY
    16. Boland, I; Vassal, G; Morizet, J; Terrier-Lacombe, MJ; Valteau-Couanet, D; Kalifa, C; Hartmann, O; Gouyette, A
      Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations

      BRITISH JOURNAL OF CANCER
    17. Avet-Loiseau, H; Venuat, AM; Terrier-Lacombe, MJ; Lellouch-Tubiana, A; Zerah, M; Vassal, G
      Comparative genome hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children

      BRITISH JOURNAL OF CANCER
    18. VASSAL G; BOLAND I; TERRIERLACOMBE MJ; WATSON AJ; MARGISON GP; VENUAT AM; MORIZET J; PARKER F; LACROIX C; LELLOUCHTUBIANA A; PIERREKAHN A; POULLAIN MG; GOUYETTE A
      ACTIVITY OF FOTEMUSTINE IN MEDULLOBLASTOMA AND MALIGNANT GLIOMA XENOGRAFTS IN RELATION TO O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE AND ALKYLPURINE-DNA N-GLYCOSYLASE ACTIVITY

      Clinical cancer research
    19. VASSAL G; BOLAND I; TERRIERLACOMBE MJ; WATSON AJ; MARGISON GP; VENUAT AM; MORIZET J; PARKER F; LACROIX C; LELLOUCHTUBIANA A; PIERREKAHN A; POULLAIN MG; GOUYETTE A
      ACTIVITY OF FOTEMUSTINE IN MEDULLOBLASTOMA AND MALIGNANT GLIOMA XENOGRAFTS IN RELATION TO O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE AND ALKYLPURINE-DNA N-GLYCOSYLASE ACTIVITY

      Clinical cancer research
    20. BOIGE V; RAYMOND E; FABBRO M; PLAZZA J; VASSAL G; RISSE ML; RODIER JM; ARMAND JP
      PHASE-II TRIAL AND PHARMACOKINETIC STUDY OF IRINOTECAN (CPT-11) IN PATIENTS WITH GLIOBLASTOMA

      Annals of oncology
    21. SALIBA F; HAGIPANTELLI R; MISSET JL; BASTIAN G; VASSAL G; BONNAY M; HERAIT P; COTE C; MAHJOUBI M; MIGNARD D; CVITKOVIC E
      PATHOPHYSIOLOGY AND THERAPY OF IRINOTECAN-INDUCED DELAYED-ONSET DIARRHEA IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - A PROSPECTIVE ASSESSMENT

      Journal of clinical oncology
    22. SMITH M; BERNSTEIN M; BLEYER WA; BORSI JD; HO P; LEWIS IJ; PEARSON A; PEIN F; PRATT C; REAMAN G; RICCARDI R; SEIBEL N; TRUEWORTHY R; UNGERLEIDER R; VASSAL G; VIETTI T
      CONDUCT OF PHASE-I TRIALS IN CHILDREN WITH CANCER

      Journal of clinical oncology
    23. VASSAL G; PONDARRE C; BOLAND I; CAPPELLI C; SANTOS A; THOMAS C; LUCCHI E; IMADALOU K; PEIN F; MORIZET J; GOUYETTE A
      PRECLINICAL DEVELOPMENT OF CAMPTOTHECIN DERIVATIVES AND CLINICAL-TRIALS IN PEDIATRIC ONCOLOGY

      Biochimie
    24. LEVU B; DEVATHAIRE F; SHAMSALDIN A; HAWKINS MM; GRIMAUD E; HARDIMAN C; DIALLO I; VASSAL G; BESSA E; CAMPBELL S; PANIS X; DALYSCHVEITZER N; LAGRANGE JL; ZUCKER JM; ESCHWEGE F; CHAVAUDRA J; LEMERLE J
      RADIATION-DOSE, CHEMOTHERAPY AND RISK OF OSTEOSARCOMA AFTER SOLID TUMORS DURING CHILDHOOD

      International journal of cancer
    25. Vassal, G
      Methodology and limits of preclinical evaluation during the development ofanticancer drug combinations

      BULLETIN DU CANCER
    26. VASSAL G; PONDARRE C; CAPPELLI C; TERRIERLACOMBE MJ; BOLAND I; MORIZET J; BENARD J; VENUAT AM; ARDOUIN P; HARTMANN O; GOUYETTE A
      DNA-TOPOISOMERASE-I, A NEW TARGET FOR THE TREATMENT OF NEUROBLASTOMA

      European journal of cancer
    27. HARTMANN O; VALTEAUCOUANET D; BENHAMOU E; VASSAL G; RUBIE H; BEAUJEAN F; LEMERLE J
      STAGE-IV NEUROBLASTOMA IN PATIENTS OVER 1 YEAR OF AGE AT DIAGNOSIS - CONSOLIDATION OF POOR RESPONDERS WITH COMBINED BUSULFAN, CYCLOPHOSPHAMIDE AND MELPHALAN FOLLOWED BY IN-VITRO MAFOSFAMIDE-PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      European journal of cancer
    28. PEIN F; DOZ F; FRAPPAZ D; LUCCHI E; MORETTI S; SANTOS D; MIGNARD D; VASSAL G
      PHASE-I TRIAL OF IRINOTECAN (CPT-11)I IN CHILDHOOD SOLID TUMORS

      European journal of cancer
    29. VASSAL G; BOLAND I; SANTOS A; BISSERY MC; TERRIERLACOMBE MJ; MORIZET J; SAINTEROSE C; LELLOUCHTUBIANA A; KALIFA C; GOUYETTE A
      POTENT THERAPEUTIC ACTIVITY OF IRINOTECAN (CPT-11) AND ITS SCHEDULE DEPENDENCY IN MEDULLOBLASTOMA XENOGRAFTS IN NUDE-MICE

      International journal of cancer
    30. RAMIREZ LH; ZHAO ZX; ROUGIER P; BOGNEL C; DZODIC R; VASSAL G; ARDOUIN P; GOUYETTE A; MUNCK JN
      PHARMACOKINETICS AND ANTITUMOR EFFECTS OF MITOXANTRONE AFTER INTRATUMORAL OR INTRAARTERIAL HEPATIC ADMINISTRATION IN RABBITS

      Cancer chemotherapy and pharmacology
    31. VASSAL G; KOSCIELNY S; CHALLINE D; VALTEAUCOUANET D; BOLAND I; DEROUSSENT A; LEMERLE J; GOUYETTE A; HARTMANN O
      BUSULFAN DISPOSITION AND HEPATIC VENOOCCLUSIVE DISEASE IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION

      Cancer chemotherapy and pharmacology
    32. GRILL J; LEDELEY MC; VALTEAUCOUANET D; VASSAL G; BONNAY M; BENHAMOU E; HARTMANN O
      PREVIOUS CONVENTIONAL CHEMOTHERAPY IS THE PRINCIPAL RISK FACTOR FOR IMMUNOGLOBULIN DEFICIENCY DURING THE EARLY POST-ABMT PERIOD IN CHILDREN

      Bone marrow transplantation
    33. VALTEAUCOUANET D; VASSAL G; PONDARRE C; BONNAY M; BENHAMOU E; COUANET D; PLANTAZ D; HARTMANN O
      PHASE-I STUDY OF HIGH-DOSE CONTINUOUS INTRAVENOUS-INFUSION OF VP-16 IN COMBINATION WITH HIGH-DOSE MELPHALAN FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CHILDREN WITH STAGE-IV NEUROBLASTOMA

      Bone marrow transplantation
    34. VASSAL G; TERRIERLACOMBE MJ; LELLOUCHTUBIANA A; VALERY CA; SAINTEROSE C; MORIZET J; ARDOUIN P; RIOU G; KALIFA C; GOUYETTE A
      TUMORIGENICITY OF CEREBELLAR PRIMITIVE NEURO-ECTODERMAL TUMORS IN ATHYMIC MICE CORRELATES WITH POOR-PROGNOSIS IN CHILDREN

      International journal of cancer
    35. VASSAL G; TERRIERLACOMBE MJ; BISSERY MC; VENUAT AM; GYERGYAY F; BENARD J; MORIZET J; BOLAND I; ARDOUIN P; BRESSACDEPAILLERETS B; GOUYETTE A
      THERAPEUTIC ACTIVITY OF CPT-11, A DNA-TOPOISOMERASE-I INHIBITOR, AGAINST PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR AND NEUROBLASTOMA XENOGRAFTS

      British Journal of Cancer
    36. DANGLOT G; REGNIER V; FAUVET D; VASSAL G; KUJAS M; BERNHEIM A
      NEUROFIBROMATOSIS-1 (NF1) MESSENGER-RNAS EXPRESSED IN THE CENTRAL-NERVOUS-SYSTEM ARE DIFFERENTIALLY SPLICED IN THE 5' PART OF THE GENE

      Human molecular genetics
    37. LECESNE A; VASSAL G; FARACE F; SPIELMANN M; LECHEVALIER T; TURSZ T; ESCUDIER B
      CONCOMITANT INTERLEUKIN-2-DOXORUBICIN (ADR) SCHEDULE IN PATIENTS (PTS) WITH ADVANCED SOFT-TISSUE SARCOMAS (ASTS) - A PHARMACOKINETIC STUDY

      European journal of cancer
    38. MISSET JL; SALIBA F; GIACCHETTI S; BRAIN E; VASSAL G; BONNAY M; BASTIAN G; COTE C; MAHJOUBI M; HERAIT P; HAGIPANTELLI R; CVITKOVIC E
      PATHOPHYSIOLOGY AND THERAPY OF IRINOTECAN (CPT-11) INDUCED DELAYED-ONSET DIARRHEA (DD) - A PROSPECTIVE ASSESSMENT

      European journal of cancer
    39. PEIN F; VASSAL G; SAKIROGLU C; TOURNADE MF; LEMERLE J
      PEDIATRIC FEATURES OF ANTHRACYCLINES CARD IAC TOXICITY AND PRACTICAL IMPLICATIONS FOR PREVENTION

      Archives de pediatrie
    40. VASSAL G; PEIN F
      LONG-TERM RISK-FACTORS OF ANTICANCER MEDI CATION FOR CHILDREN

      Archives de pediatrie
    41. CANIONI D; VASSAL G; DONADIEU J; HUBERT P; BROUSSE N
      TOXICITY INDUCED BY CHEMOTHERAPY MIMICKING CYTOMEGALOVIRUS GASTRITIS

      Histopathology
    42. AUTRET E; VASMANT D; BEGAUD B; DUPORTAL HD; BOUTROY MJ; CEZARD JP; DELBOS L; ESCHWEGE E; GOUJARD J; ICHOU F; JACQZAIGRAIN E; KOUZAN S; LASSALE C; LEROY B; OSTINELLI J; PLETAN Y; PONS G; SAUVANET JP; SINGLAS E; TABURET AM; THERENEFENOGLIO MC; TILLEMENT JP; VASSAL G; SAINTSALVY B
      DETERMINATION OF DRUG-DOSAGE IN PEDIATRIC S

      Therapie
    43. VASSAL G
      PHARMACOLOGICALLY-GUIDED DOSE ADJUSTMENT OF BUSULFAN IN HIGH-DOSE CHEMOTHERAPY REGIMENS - RATIONALE AND PITFALLS

      Anticancer research
    44. VASSAL G; PEIN F; GOUYETTE A; LEMERLE J
      DEVELOPMENT OF NEW ANTICANCER AGENTS IN C HILDREN - METHODOLOGY, DIFFICULTIES, AND STRATEGIES

      Annales de pediatrie
    45. VASSAL G
      THERAPEUTIC DEVELOPMENT AND CLINICAL-PHAR MACOLOGY IN PEDIATRIC ONCOLOGY

      Annales de pediatrie
    46. VASSAL G; BOLAND I; DEROUSSENT A; GEORGIN D; NOEL JP; GOUYETTE A
      IN-VITRO BUSULFAN METABOLISM IN HUMAN AND MOUSE-LIVER

      Bulletin du cancer
    47. VASSAL G; FISCHER A; CHALLINE D; BOLAND I; LEDHEIST F; LEMERLE S; VILMER E; RAHIMY C; SOUILLET G; GLUCKMAN E; MICHEL G; DEROUSSENT A; GOUYETTE A
      BUSULFAN DISPOSITION BELOW THE AGE OF 3 - ALTERATION IN CHILDREN WITHLYSOSOMAL STORAGE DISEASE

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 01:03:23